Thalidomide and Leprosy: Did the FDA Err in 1961? Essay

Open, View, and/or
Download this Document

Total Length: 662 words ( 2 double-spaced pages)

Total Sources: 2

Page 1 of 2

Thalidomide

Although the United States succeeded in averting the same thalidomide tragedy that occurred in Europe by refusing to approve the drug, some observers counter that the action introduced unnecessary delays in the approval of many useful drugs. Given that thalidomide is now accepted as an effective treatment for leprosy, this paper provides an evaluation concerning whether Dr. Frances Kelsey was correct in stopping the development of thalidomide in the United States in 1960, followed by a summary of the research and important findings in the conclusion.

In 1961, two doctors working independently in Australia and Germany determined that thalidomide, a sedative and n anti-nausea drug that was being prescribed for pregnant women, was responsible for a wave of birth defects (Carpenter, 2010). Based on their analysis of the available data concerning thalidomide, the two physicians, Drs. McBridge and Lenz, determined that thalidomide caused birth defects when taken during the first trimester of pregnancy (Carpenter, 2010). In this regard, Carpenter reports that, "Tragically, thousands of pregnant women had taken thalidomide during this window of pregnancy because of its utility as an anti-nausea drug" (2010, p. 240). Besides the dozens of high-profile physical deformities caused by thalidomide, there were additional uncounted thousands who suffered from brain and internal organ damage (Carpenter, 2010).

Stuck Writing Your "Thalidomide and Leprosy: Did the FDA Err in 1961?" Essay?

View All Our Example Thalidomide and Leprosy: Did the FDA Err in 1961? Essay

Have A Custom Example Essay Written

In addition, the actual number of women who experienced stillbirths as a result of taking thalidomide have never been determined (Carpenter, 2010). In addition, Brown (2009) estimates that approximately 10,000 infants had been born with severe limb malformations by 1961 to women who took thalidomide during their pregnancies and countless more were aborted.

Following the two physician's warnings, the drug was recalled from European markets by the European drug manufacturer; however, the U.S. pharmaceutical company, Merrell, continued to press its claims for approval of thalidomide to Dr. Frances Kelsey, a medical officer with the Food & Drug Administration, that the mounting evidence from Europe was erroneous with respect to the birth abnormalities and the drug should still be approved in the United States (Carpenter, 2010). According to Carpenter, "Kelsey rejected this assertion and again imposed the burden of proof upon Merrell. As the stories became more numerous and as the link between drug and defects became clearer, Merrell quietly withdrew the new drug application in March 1962" (2010, p. 240). Consequently, while more than a million of doses of thalidomide were being taken by pregnant women in….....

Show More ⇣

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Thalidomide And Leprosy Did The FDA Err In 1961 " (2014, December 04) Retrieved May 21, 2025, from
https://www.aceyourpaper.com/essays/thalidomide-leprosy-fda-err-1961-2154408

Latest MLA Format (8th edition)

Copy Reference
"Thalidomide And Leprosy Did The FDA Err In 1961 " 04 December 2014. Web.21 May. 2025. <
https://www.aceyourpaper.com/essays/thalidomide-leprosy-fda-err-1961-2154408>

Latest Chicago Format (16th edition)

Copy Reference
"Thalidomide And Leprosy Did The FDA Err In 1961 ", 04 December 2014, Accessed.21 May. 2025,
https://www.aceyourpaper.com/essays/thalidomide-leprosy-fda-err-1961-2154408
   

Open, View, and/or
Download this Document
order custom essay example